Raymond James & Associates’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $49.1M | Buy |
249,037
+925
| +0.4% | +$192K | 0.03% | 444 |
|
|
2024
Q2 | $51.3M | Sell |
248,112
-236
| -0.1% | -$53.5K | 0.03% | 409 |
|
|
2024
Q1 | $67.3M | Buy |
248,348
+4,660
| +2% | +$1.11M | 0.05% | 346 |
|
|
2023
Q4 | $57.6M | Sell |
243,688
-8,488
| -3% | -$1.67M | 0.04% | 350 |
|
|
2023
Q3 | $49.4M | Buy |
252,176
+6,013
| +2% | +$1.23M | 0.04% | 353 |
|
|
2023
Q2 | $51.8M | Buy |
246,163
+13,793
| +6% | +$2.74M | 0.04% | 351 |
|
|
2023
Q1 | $46.9M | Buy |
232,370
+8,653
| +4% | +$1.96M | 0.04% | 375 |
|
|
2022
Q4 | $48.7M | Sell |
223,717
-7,786
| -3% | -$1.7M | 0.04% | 351 |
|
|
2022
Q3 | $45.6M | Buy |
231,503
+107,047
| +86% | +$23.1M | 0.05% | 341 |
|
|
2022
Q2 | $26.6M | Buy |
124,456
+8,783
| +8% | +$2.15M | 0.03% | 508 |
|
|
2022
Q1 | $32.8M | Sell |
115,673
-98,062
| -46% | -$30.2M | 0.03% | 492 |
|
|
2021
Q4 | $80.5M | Buy |
213,735
+33,607
| +19% | +$13.1M | 0.07% | 259 |
|
|
2021
Q3 | $74.3M | Buy |
180,128
+8,670
| +5% | +$3.6M | 0.07% | 251 |
|
|
2021
Q2 | $63.4M | Buy |
171,458
+11,332
| +7% | +$3.78M | 0.06% | 284 |
|
|
2021
Q1 | $46.4M | Buy |
160,126
+30,229
| +23% | +$8.4M | 0.05% | 339 |
|
|
2020
Q4 | $32.5M | Buy |
129,897
+22,817
| +21% | +$5.43M | 0.04% | 423 |
|
|
2020
Q3 | $24.2M | Buy |
107,080
+13,745
| +15% | +$2.85M | 0.03% | 472 |
|
|
2020
Q2 | $16.3M | Buy |
93,335
+12,352
| +15% | +$1.97M | 0.02% | 605 |
|
|
2020
Q1 | $10.2M | Buy |
80,983
+5,937
| +8% | +$890K | 0.02% | 739 |
|
|
2019
Q4 | $11.5M | Buy |
75,046
+4,795
| +7% | +$664K | 0.01% | 837 |
|
|
2019
Q3 | $9.3M | Buy |
70,251
+12,466
| +22% | +$1.67M | 0.01% | 895 |
|
|
2019
Q2 | $8.2M | Buy |
57,785
+19,387
| +50% | +$2.63M | 0.01% | 959 |
|
|
2019
Q1 | $5.58M | Buy |
38,398
+6,133
| +19% | +$806K | 0.01% | 1133 |
|
|
2018
Q4 | $3.65M | Buy |
32,265
+1,114
| +4% | +$139K | 0.01% | 1259 |
|
|
2018
Q3 | $4.19M | Buy |
+31,151
| New | +$3.84M | 0.01% | 1322 |
|
|
2018
Q1 | – | Sell |
-4,848
| Closed | -$531K | – | 3478 |
|
|
2017
Q4 | $531K | Buy |
4,848
+826
| +21% | +$89.9K | ﹤0.01% | 2499 |
|
|
2017
Q3 | $434K | Buy |
4,022
+288
| +8% | +$29.6K | ﹤0.01% | 2558 |
|
|
2017
Q2 | $378K | Sell |
3,734
-1,783
| -32% | -$164K | ﹤0.01% | 2578 |
|
|
2017
Q1 | $496K | Buy |
+5,517
| New | +$469K | ﹤0.01% | 2380 |
|
|
2016
Q4 | – | Sell |
-30,488
| Closed | -$2.54M | – | 3260 |
|
|
2016
Q3 | $2.54M | Buy |
30,488
+5,519
| +22% | +$463K | 0.01% | 1317 |
|
|
2016
Q2 | $2.06M | Buy |
+24,969
| New | +$2.06M | 0.01% | 1314 |
|
|
2015
Q4 | – | Sell |
-32,888
| Closed | -$2.09M | – | 2336 |
|
|
2015
Q3 | $2.09M | Buy |
32,888
+10,666
| +48% | +$766K | 0.01% | 1193 |
|
|
2015
Q2 | $1.56M | Buy |
+22,222
| New | +$1.64M | 0.01% | 1467 |
|
Other funds holding CRL
MG
EC